Related Experiment Video

Updated: Jun 6, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Coexistence of CACNA1A, ATP1A2, and KCNN3 gene mutation in migraine patients with human platelet polymorphism

Shalini Bhaskar1, Jafri M Abdullah, Mazira M Ghazali

  • 1Department of Medicine, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia. Tel. +60 97663456/+60 129851339. Fax. +60 97648613.

Neurosciences (Riyadh, Saudi Arabia)
|November 11, 2010
PubMed

Insights

This study investigated gene mutations in migraine patients with human platelet polymorphism. One patient with CACNA1A gene mutation was found, but no link to ATP1A2 or KCNN3 mutations.

Area of Science:

  • Genetics
  • Neurology
  • Hematology

Background:

  • Migraine is a complex neurological disorder.
  • Platelet polymorphism, specifically HPA-1a/1b (PlA1/A2), has been studied in relation to various conditions.
  • Specific gene mutations (CACNA1A, ATP1A2, KCNN3) are implicated in neurological functions.

Purpose of the Study:

  • To investigate the coexistence of CACNA1A, ATP1A2, and KCNN3 gene mutations in migraine patients with HPA-1a/1b polymorphism.
  • To determine potential genetic links between platelet variations and migraine susceptibility.

Main Methods:

  • DNA analysis using polymerase chain reaction (PCR) and allele-specific oligonucleotide (ASO) technique.
  • Genotyping for CACNA1A, ATP1A2, and KCNN3 in 4 migraine patients with HPA-1a/1b polymorphism.
  • Study conducted at Hospital University Sains Malaysia between April 2004 and March 2005.

Main Results:

  • A CACNA1A gene mutation was identified in one patient with classical migraine with aura.
  • No mutations in the ATP1A2 and KCNN3 genes were detected in any of the four migraine patients.
  • The study found no coexistence between HPA-1a/1b polymorphism and ATP1A2/KCNN3 mutations.

Conclusions:

  • There is no observed coexistence between platelet HPA-1a/1b polymorphism and ATP1A2/KCNN3 gene mutations in this small cohort.
  • A single case suggests a potential association between CACNA1A mutation and migraine in patients with HPA-1a/1b polymorphism.
  • Larger-scale studies are necessary to validate these preliminary findings and explore genetic associations in migraine.
Abstract

More Related Videos

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays12:48

Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays

Published on: February 19, 2013

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents08:39

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents

Published on: May 16, 2022

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...